🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 22 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
31/07/2006 15,48 17,10 15,48 16,98 +9,69% 10,47% 107.133
28/07/2006 15,78 16,62 15,30 15,48 -0,77% 8,37% 119.417
27/07/2006 17,40 17,40 15,54 15,60 -9,41% 10,69% 206.333
26/07/2006 17,76 18,00 17,10 17,22 -3,69% 5,07% 116.167
25/07/2006 18,06 18,78 17,64 17,88 -1,32% 6,31% 73.967
24/07/2006 17,52 18,30 17,52 18,12 +4,14% 4,45% 142.133
21/07/2006 18,54 18,60 17,22 17,40 -6,15% 7,44% 94.717
20/07/2006 19,26 19,62 18,42 18,54 -3,13% 6,23% 46.400
19/07/2006 18,24 19,38 18,24 19,14 +5,28% 6,25% 72.217
18/07/2006 19,68 19,80 17,82 18,18 -6,77% 10,06% 142.700
17/07/2006 19,44 19,68 18,24 19,50 -0,31% 7,41% 146.017
14/07/2006 20,22 20,40 19,50 19,56 -3,55% 4,45% 107.750
13/07/2006 21,06 21,48 20,22 20,28 -3,43% 5,98% 72.450
12/07/2006 21,18 21,90 20,94 21,00 -1,41% 4,53% 54.533
11/07/2006 20,94 21,30 20,76 21,30 +1,14% 2,58% 47.250
10/07/2006 20,88 21,18 20,82 21,06 +0,29% 1,72% 77.750
07/07/2006 21,30 21,84 20,76 21,00 -0,57% 5,07% 79.317
06/07/2006 21,96 22,08 21,12 21,12 -4,35% 4,37% 74.033
05/07/2006 22,14 22,14 21,18 22,08 -0,81% 4,34% 128.667
03/07/2006 22,56 22,56 21,90 22,26 -1,07% 2,93% 48.267
30/06/2006 22,50 23,52 21,84 22,50 +0,54% 7,47% 870.183
29/06/2006 22,74 22,98 21,36 22,38 -0,27% 7,12% 90.400
28/06/2006 22,44 22,74 21,30 22,44 +0,81% 6,42% 94.867
27/06/2006 24,48 24,60 22,20 22,26 -8,40% 9,80% 84.967
26/06/2006 24,18 24,60 24,00 24,30 +1,00% 2,48% 40.033
23/06/2006 23,82 24,54 23,52 24,06 +1,26% 4,28% 53.233
22/06/2006 23,58 24,18 22,92 23,76 +2,59% 5,34% 65.200
21/06/2006 22,92 23,76 22,68 23,16 +1,58% 4,71% 48.883
20/06/2006 22,80 23,16 22,26 22,80 -0,52% 3,95% 73.367
19/06/2006 23,22 23,52 22,50 22,92 -1,80% 4,39% 83.033